摘要
目的:评价氧驱动雾化吸入疗法在中、重度支气管哮喘急性发作治疗中的作用。方法:将55例符合诊断支气管哮喘急性发作期的患者,随机分为治疗组28例,对照组27例。两组都予甲基强的松龙、多索茶碱、吸氧、抗生素等常规治疗,在此基础上,对照组予硫酸特布他林片口服;治疗组予氧驱动雾化吸入硫酸特布他林雾化液。结果:治疗组在喘憋消失时间、哮鸣音消失时间、住院天数及肺功能改善方面与对照组比较差异有统计学意义(P<0.01,P<0.05)。结论:氧驱动雾化吸入疗法治疗中重度支气管哮喘急性发作期显示良好疗效,所以在临床用药抢救患者时,基层医院若条件许可,应大力推广。
Objective To evaluate the therapeutic efficacy of oxygen-driven aerosol inhalation for acute episode intermediate or severe degree of bronchial asthma.Method A total of 55 patients with bronchial asthma were divided into two groups randomly.The control group（n=27） was treated with terbutaline sulfate tablets and the treatment group （n=28） was treated with terbutaline sulphate aerosol fluid by oxygen-driven aerosol inhalation on the basis of conventional therapies,for example methylprednisolone,Doxofylline,oxygen and antibiotics.Results The disappearance time of asthma and sound,hospitalization days and the improvement of lung function showed significant differences between the two groups（P0.01,P0.05）.Conclusion Oxygen-driven aerosol inhalation therapy for acute episode intermediate or severe degree of bronchial asthma shows good effect.So if conditions permitted,the primary hospitals should be vigorously promoted when rescuing the patients with clinical medicine.
出处
《吉林医学》
CAS
2010年第35期6457-6458,共2页
Jilin Medical Journal
关键词
支气管哮喘
硫酸特布他林
雾化吸入
Bronchial asthma
Terbutaline sulphate
Aerosol inhalation
